Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
Condition(s):Breast CancerLast Updated:July 5, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:July 5, 2023Completed
Condition(s):Breast CancerLast Updated:February 28, 2013Completed
Condition(s):Breast NeoplasmsLast Updated:September 29, 2008Completed
Condition(s):Stage 0 Breast Cancer AJCC v6 and v7; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7Last Updated:August 22, 2023Completed
Condition(s):Breast NeoplasmsLast Updated:March 25, 2019Completed
Condition(s):Metastatic or Locally-advanced Unresectable Breast CancerLast Updated:March 2, 2022Completed
Condition(s):Breast CancerLast Updated:May 2, 2017Completed
Condition(s):Metastatic Breast CancerLast Updated:April 8, 2019Unknown status
Condition(s):Breast CancerLast Updated:March 6, 2023Completed
Condition(s):Breast CancerLast Updated:April 27, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.